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\s=b\We studied the immunologic function of 19 sexually active
homosexual men, ten of whom had persistent lymphadenopa-
thy. Analysis of mononuclear cell populations distinguished
homosexuals from heterosexual controls since, as a group,
homosexuals had increased percentages of natural killer cells(Leu 7+), decreased helper-inducer T lymphocytes (OKT-4+),
increased suppressor/cytotoxic (OKT-8+) T lymphocytes, low
OKT-4:OKT-8 ratios, and depressed mitogenic responses. Ho-
mosexuals without lymphadenopathy were distinguishable
from controls by increased percentages of la+ cells, de-
creased OKT-4+ cells, and decreased OKT-4:OKT-8 ratios.
Four had positive findings simultaneously for hepatitis B
surface antigen (HBsAg) and surface antibody, and five had
positive findings for HBsAg alone. Homosexuals with lymph-
adenopathy were distinguishable from controls by increased
percentages of Leu 7+ cells, increased total lymphocyte
numbers per cubic millimeter, decreased percentages of both
OKT-4+ and OKT-8+ cells, abnormal OKT-4:OKT-8 ratios, and
depressed mitogenic responses. Only histories of larger num-
bers of sexually acquired diseases, higher numbers of OKT-8+
cells per cubic millimeter, and lower mitogenic responses in
homosexuals with lymphadenopathy distinguished this group
from homosexuals without lymphadenopathy. Furthermore,
none of the nine patients tested in this group was HBsAg
positive. We conclude that homosexuals without lymph-
adenopathy are distinguishable from those with lymph-
adenopathy by both immunologic and serologic abnormali-
ties.
(Arch Intern Med 1984;144:1153-1158)
 syndrome of chronic, generalized lymphadenopathy
 " has recently been noted in homosexual men and pa¬
tients receiving transfusions of blood or blood products.1"4
The exact relationship of this syndrome to the development
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of the acquired immune deficiency syndrome (AIDS) in
these same patient groups is unclear. At least two observa¬
tions suggest that the two may be related. First, persistent
lymphadenopathy has preceded the development of AIDS
in homosexuals.5,6 Second, similar, apparently specific his-
topathologic findings have been noted in lymph nodes from
homosexuals with isolated lymphadenopathy and AIDS.7
We report the results of an extensive immunologie in¬
vestigation of 19 sexually active homosexual males, ten of
whom had persistent lymphadenopathy. Patients with
lymphadenopathy had greater numbers of sexually ac¬
quired diseases, and a lymphocytosis with an increase of
total T-suppressor/cytotoxic cells that distinguished the
group from both controls and homosexuals without
lymphadenopathy. Lymphocyte mitogenic responses also
distinguished both homosexual groups from each other and
were profoundly abnormal in patients with lymphadenopa¬
thy.
SUBJECTS AND METHODS
Study Population
The 19 homosexual males studied were examined at the Ochsner
Medical Institution or Tulane Medical Center, New Orleans. All of
the patients were initially self-referred and requested medical care
and long-term follow-up. All lived in the New Orleans area and
most were seen as outpatients.
Extensive histories were taken from each patient to obtain data
on the numbers and types of previous sexually acquired diseases,
drug abuse, use of bathhouses, and frequency of sexual exposure.
Patients were questioned specifically about recent weight loss,
malaise, anorexia, or recurrent infections. Available medical rec¬
ords were also reviewed. An extensive physical examination was
performed with special attention to detect lymphadenopathy.
Nineteen healthy heterosexual men age-matched to the homo¬
sexual study group served as controls for the immunologie tests
performed.
Immunologie Evaluation
Delayed hypersensitivity skin tests were performed as previ¬
ously described8 and induration recorded at 24 and 48 hours. Skin
test antigens included at least five of the following antigens:
purified protein derivative (5 tuberculin units), Candida albicane(1:100), streptokinase-streptodornase (4 units streptokinase/
40 units streptodornase), mumps (2 colony-forming units), tri-
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Table 1.—Clinical Data on Homosexuals in Study*
Patient No./
Age, yr
Reason for
Consultation
Other
Complaints
Previous Sexually
Transmitted Diseases
History of
IV Drug Abuse
History of
Nitrite Use
Other
Diagnoses
1/50
2/41
3/65
4/39
5/35
6/25
7/37
8/27
9/24
10/25
111720
121739
131733
141732
15/37
16/32
171731
18/43
19/35
Herpes zoster
Sexual partner
had AIDS
Acute proctitis
AIDS evaluation
Cutaneous herpes
Follow-up for
hepatitis
AIDS evaluation
Headaches
Follow-up of
previous hepatitis
Diarrhea
Bloody diarrhea
Sore throat
Skin lesions
Lymphadenopathy
Sore throat
Lymphadenopathy
Lymphadenopathy,
penile discharge
Lymphadenopathy
Wart on penis
Headache,
undocumented fever
None
None
None
None
None
Patients Without Lymphadenopathy
Hepatitis  
Hepatitis  
Hepatitis  
None
Hepatitis B,
condyloma acumlnatum
Hepatitis B, syphilis,
gonococcal urethritls
Fatigue, undocumented Hepatitis  
weight loss
Recurrent upper
respiratory tract
infections, fatigue
Fatigue
Hepatitis  
Hepatitis  
None
Fever, weight loss
None
Malaise
None
None
None
None
Recurrent urinary
and respiratory
tract infections
Weight loss,
malaise
Patients With Lymphadenopathy
Syphilis, urethritis,
hepatitis  
Syphilis
Gonococcal
urethritis, proctitis,
syphilis, amoebic
dysentery, hepatitis  
Gonococcal urethritis,
hepatitis  
Syphilis, gonococcal
proctitis, hepatitis  
Syphilis, dysentery
Syphilis, hepatitl:
Hepatitis  
Syphilis, condyloma
acumlnatum, amebiasis,
hepatitis  
Syphilis, condyloma
acuminatum, hepatitis  
No
No
No
Unclear
No
No
No
No
Yes
No
No
No
No
No
 
  
-  ;  ;; . ;.:.,.    
No
Unclear
Unclear
No
No
Yes
Yes
No
No
Yes
Yes
Unclear
No
No
No
No
Yes
Yes
Yes
No
Yes
Unclear
No
Yes
Herpes zoster,
HBsAg positive
None,
HBsAg positive
Condyloma
acuminatum
Epidermal cysts,
recurrent
Cutaneous herpes
None
Chronic persistent
hepatitis,
HBsAg positive
Chronic persistent
hepatitis,
HBsAg positive
HBsAg positive
Chlamydial
proctitis
Acute proctitis,
cause unknown
Gonorrheal
pharangitis
Secondary
syphilis
None
Candida
esophagitis
None
Nonspecific
urethritis
None
Condyloma latum
*AIDS indicates acquired immune deficiency syndrome; HBsAg, hepatitis-B surface antigen; IV, Intravenous.
tLymph node biopsy specimen showed reactive hyperplasia.
chophytin (1:60), tetanus toxoid (1:100), and histoplasmin (1:100).
Tests were judged positive if 10 mm or more of induration was
present at either time period. Patients failing to react to any skin
test antigen were judged "anergic" and their skin test results
considered negative.
Serologie Studies.—Serum samples were analyzed for the
presence of hepatitis  surface antigen (HBsAg) and IgG antibody
to hepatitis  surface antigen (HBsAb) by radioimmunoassay
using commercial reagents.910 The presence of complement-fixing
antibody in the serum for cytomegalovirus (CMV) and herpes
simplex was determined by indirect fluorescence (FIAX Test
Kit).11 Antibodies to Toxoplasma were also determined by that
technique,12 as were antibodies to Treponema pallidum.
Evaluation of Mononuclear Cell Populations.—Peripheral
blood mononuclear cell populations were isolated from whole blood
by density-gradient separation over Hypaque-Ficoll. Mononuclear
cell populations were detected using monoclonal antibodies,
 -rosette reactive cells (OKT-11), T-helper/T-inducer cells(OKT-4), and T-suppressor/cytotoxic cells (OKT-8).13 Cells bearing
la-matrix antigen (monoclonal antibody HLA-DR) and the natural
killer-cell antigen (Leu 7) were also detected using monoclonal
antibodies.1415 These studies were performed by direct immunoflu-
orescence with counting on a fluorescence-activated cell sorter(FACS III). Each analysis consisted of 25,000 cells utilizing the
488-nm laser line with the following gain settings of scatter: 4x5
and fluorescence: 2  1 at 500 mV. The percent of positive cells was
calculated after correction for background staining with daily
results confirmed by fluorescence microscopy. B-lymphocyte per¬
centages were similarly determined using polyclonal F(ab')2 goat
antihuman immunoglobulin.16 Total numbers of lymphocytes were
calculated by multiplying the leukocyte count by the percentage of
lymphocytes in the differential cell count. Absolute numbers of
lymphocyte subpopulations were calculated by multiplication of
their percentages by the total lymphocyte count with results
expressed as cells per cubic millimeter. Staining of monocytes in
mononuclear cell preparations was performed using a-naphthyl-
butyrate esterase stain.17 Serum immunoglobulin determinations(IgG, IgM, and IgA) were performed by nephelometry using
commercial reagents.
Lymphocyte proliferation induced by the T-cell mitogen phyto-
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Table 2.—Laboratory Data on Homosexuals in Study*
Toxoplasma Herpes CMV Positive Delayed Serum Serum Serum WBC/cu mm PMN/cu mm
HBsAg HBsAb RPR FTA-ABS Titert Titerj Tlter§ Skin Testjj_IgGI IgM IgA_ 10»_xlO3»
Patients Without Lymphadenopathy
5/9 7/9 0/7 1/4 0/7 7/7 7/7 6/8 1,942 ±638 208 + 50 254 ±29 6.80 ±0.88 3.84 ±0.55(873-5,010) (46-391) (187-377) (3.5-11.9) (2.1-7.2)
Patients With Lymphadenopathy
0/9 7/9 7/8 6/8 2/7 3/5 4/6 4/6 1,920±402 214±32 348±85 6.46±0.89 2.83±0.37(912-3,950) (107-388) (140-650) (2.7-12.3) (1.1-5.3)
*HBsAg Indicates hepatitis  surface antigen; HBsAB, hepatitis  surface antibody; RPR, rapid plasma reagin; and CMV, cytomegalovlrus.
fTiter of greater than 1:16 is considered positive.$Titer of greater than 1:8 is considered positive.§Titer of greater than 1:8 is considered positive.
Positive to one or more of five skin test antigens as described in the text.
HReported as mean± SEM and range of values in mg/dL.
#PMN indicates polymorphonuclear leukocytes.
Table 3.—Mononuclear Cell Populations in Homosexuals and Control Subjects
%  Cells % Monocytes % Leu 7 % la+ % OKT-11 % OKT-3
Lymphocytes  
103/cu mm
Control subjects
Homosexuals
Group 1
Group 2
12.2±1.0
9.9 ±1.5
8.1 ±1.8
9.3 ±1.4
18.8±1.5
18.7 + 1.8
20.2 ±3.1
16.9±2.1
9.2±1.0
14.0±1.8*
13.2±3.1
15.0±2.6*
26.5±1.5
30.9 ±2.8
34.1 ±3.8*
27.9 ±4.0
71.3 ±1.34
70.0±4.5
67.5±3.8
73.0±2.7
59.3±1.8
58.0 ±2.9
56.8±4.5
58.6±4.2
2.2-0.13
2.78 ±0.40
2.48 ±0.43
3.06* ±0.68
*P£.05 when compared with control values. Data are reported as mean ± SEM.
Table 4.—T-Lymphocyte Subpopulations in Homosexuals and Control Subjects
% OKT-4 Total OKT-4/CU mm % OKT-8 Total OKT-8/CU mm OKT-4:OKT-8 Ratio
Control subjects
Homosexuals
Group 1
Group 2
35.1 ±1.5
26.0 ±2.4*
25.9±3.8*
26.3±3.2*
849 ±61
809 ±120
745 ±179
866 ±168
22.5±1.7
29.0 ±2.3*
26.0±2.0
31.8 ±3.9*
554 ±56
929 ±173*
668 ±82
1,164±309*t
1.76±0.14
1.06±0.15*
1.05±0.18*
1.08 + 0.24*
*PF.05 when compared with control value. Data are reported as mean ± SEM.
tPF.10 when compared with group 1 value.
hemagglutinin (PHA) was evaluated across a dose range of 1 to
50 mg/L of PHA. Standard microculture techniques were employed
with 1  10 mononuclear cells per well in round-bottomed plates,
and RPMI 1640 media containing 10% heat inactivated pooled
human serum and antibiotics. Cells were cultured for four days,
the time of maximum response in our system.18 Cultures were
harvested using an automated cell harvester 16 hours after the
addition of 1 µ  ; per well of tritiated thymidine. Radiolabeled
nucleotide was assayed in a liquid scintillation counter and re¬
corded as counts per minute, where counts per minute were equal
to cell cultures stimulated with PHA less counts per minute from
similar but unstimulated cultures.
Statistical Analysis
Statistical analyses were performed using Student's t test ad¬justed for multiple comparisons19 and (for PHA dose-response
curves) analysis of variance and covariance with repeated mea¬
sures.20
RESULTS
Clinical Characteristics of the Study Population
Homosexuals in the study ranged from 20 to 65 years of
age (Table 1). All were sexually active and many visited
bathhouses. However, data as to the number and frequency
of sexual contacts were thought to be too equivocal to allow
comparisons among patients and are not reported. Nine
patients acknowledged use of nitrites but only one admitted
intravenous drug abuse. Most patients had histories of
multiple sexually transmitted diseases.
A variety of complaints resulted in request for initial
medical evaluation; no single complaint was predominant.
Eight patients had histories of fever, weight loss, malaise,
fatigue, or recurrent viral infections. Two patients (pa¬
tients 1 and 5) had active herpes infections at the time of
study.
Patients could be grouped into two groups on the basis of
the absence (group 1) or presence (group 2) of generalized
lymphadenopathy. The ten patients in group 2 were diag¬
nosed as having the "benign reactive lymphadenopathic
syndrome"1 by the presence of chronic, unexplained lym¬
phadenopathy of at least two months' duration with at least
three nodes greater than 1.5 cm at two or more extra-
inguinal sites. All of these individuals were subsequently
observed for at least one additional month after the study,
during which time their lymphadenopathy persisted. Dur¬
ing the course of the study, additional diagnoses were made
and are listed in Table 1.
Two group 2 patients (patients 13 and 19) had secondary
luetic lesions treated previous to our immunologie evalua¬
tion. Thus, syphilis provided a possible explanation for
their lymphadenopathy. However, lymphadenopathy pre¬
dated the skin lesions of patient 13 by six months, and he
described a primary lesion that occurred after the onset of
lymphadenopathy. Syphilis, therefore, seems an unlikely
explanation for the lymphadenopathy. The lymphadenopa¬
thy of patient 13 persisted despite adequate therapy for
syphilis, as did the lymphadenopathy in patient 19.
One patient in group 1 (patient 6) and two patients in
group 2 (patients 10 and 15) were leukopenic (total leukocyte
count, <4,300/cu mm). Three patients (two in group 1,
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PHA Dose, mg/L
Dose-response curves to mitogen phytohemagglutinin (PHA) in
control subjects, combined homosexual groups (all HS), nine
homosexuals without lymphadenopathy (group 1 ), and ten homo¬
sexuals with lymphadenopathy (group 2). Results are expressed as
means ±SEMs.
patients 1 and 6, and one in group 2, patient 15) were
lymphopenic (lymphocyte count, ^1,500/cu mm). No pa¬
tient was neutropenic (neutrophil count, sl,100/cu mm).
Immunologie Evaluation
Serologie Studies.—Fifteen of 18 patients tested had
serologie markers for hepatitis B. Five patients, all in group
1, had detectable HBsAg, but 14 patients among the two
groups had HBsAb (Table 2). Four patients in group 1 had
simultaneous positive results for HBsAg an HBsAb. Of the
patients tested, 11 of 13 had detectable antibody to CMV,
and ten of 12 had antibody to herpes simplex virus. Anti¬
bodies to Toxoplasma were uncommon. Positive serologie
findings for syphilis were present in six of eight patients
tested in group 2, but in only one of nine patients in group 1.
Mean values of serum IgG and IgM in both groups were
significantly greater (P<.05) than those of the 19 controls(Table 2). The mean IgA value for group 2 was greater than
that of group 1 but not significantly so. Control values were
1,133 ±59 mg/dL for IgG, 138 ±16 mg/mL for IgM, and
255 ±25 mg/mL for IgA. Serum immunoglobulin values
were not notably different among the two groups of homo¬
sexuals.
Mononuclear Cell Populations.—Percentages and total
numbers per cubic millimeter of mononuclear cell popula¬
tions were determined. Although both values are dis¬
cussed, percentages, but not absolute numbers, are shown
in Table 3.
Percentages of monocytes,  lymphocytes, and  cells,
were not different among controls and homosexuals or the
two homosexual groups. The total lymphocyte count in
homosexuals with lymphadenopathy (group 2) was signifi¬
cantly greater (Ps.05) than that of the control group; it was
also greater, although not significantly so (Pa.05), than the
total lymphocyte count of patients without lymphadenopa¬
thy (group 1). Cells with the surface antigen associated with
natural killer-cell activity (Leu 7) were significantly greater(Ps.05) in percentage and absolute number in group 2
patients as compared with control values. The percentage of
these cells in group 2 patients was larger than in group 1,
but not significantly so (P>.05). In contrast, percentages of
Ia+ cells were greater in group 1 patients than in controls,
while values in group 2 were similar to those seen in
controls. Total numbers of both Ia+ and Leu 7 + cells were
significantly greater (Ps.05) in groups 1 and 2, respec¬
tively, than in the control group, but not different among the
two homosexual groups.
T-Lymphocyte Subpopulations.—Percentages, but not
total numbers, of OKT-4+ were significantly reduced(Ps.05) in both homosexual groups as compared with
controls, but were not different among the two groups(Table 4). Percentages and total numbers of OKT-8+ were
significantly increased (Ps.05) only in group 2 homosex¬
uals. Ratios of OKT-4:OKT-8 lymphocytes were lower than
control values in both homosexual groups but not different
among the groups.
Skin Test and Lymphocyte Mitogenic Responses.—
Eight homosexuals in each group completed delayed hyper-
sensitivity skin testing. Results were similar in both
groups; six were positive to one or more antigens, and two
were negative.
Lymphocyte proliferative responses to the mitogen PHA
were depressed across the entire range of PHA doses in the
homosexual group (Figure). Although PHA responses were
lower in group 1 patients than those of controls, the group 1
dose-response curves were not notably different from the
control curve. Dose-response curves of group 2 patients
were significantly different (Ps.05) from those of group 1
homosexuals, the homosexual group as a whole, and control
values.
Analysis of Immunologie Variables in Asymptomatic
Patient Subgroups.—Results of immunologie studies in
seven patients who had no systemic complaints (ie, no
malaise, fatigue, weight loss, or fever), no active or recent
clinical illness, and who were neither leukopenic nor lym-
phopenic, were analyzed. This analysis included data from
patients 2, 3, and 4 in group 1 and patients 12,14,16, and 17
from group 2. Results of analysis of mononuclear cell
populations in these subgroups of groups 1 and 2 were
similar to those in the intact groups. For instance, percent¬
ages of OKT-4+ (21.3 ±2.6  23.4 ±2.6) and OKT-8 +(23.4±1.7  30.8±5.7)  cells were not significantly differ¬
ent (P>.05) between the group 1 and group 2 subgroups,
respectively. Total numbers of OKT-8+ cells were greater
in the group 2 subgroup (1,414 ±65  863 ±148), although
these values were not significant at the P<.05 level. Ratios
of T-lymphocyte subsets (OKT-4:OKT-8) from group 1(0.90 ±0.7) and group 2 (0.93 ±0.3) were not significantly
different (Pa.05). Dose-response curves to PHA were more
severely depressed in the patients with lymphadenopa¬
thy at all PHA doses than in those without, but the two
dose-response curves were not significantly different at the
Ps.05 level. However, differences in responses were
large. For instance, at the peak mitogenic dose of
20 mg/L, responses in the subset of patients from group 1
averaged 74,478 ±21,686, while those from group 2 were
28,098 ±11,858.
COMMENT
A number of reports have appeared recently describing
the clinical features of AIDS in homosexual men. It appears
that the syndrome represents a spectrum ofdisease consist¬
ing of at least the following three entities: (1) immunologie
abnormalities in otherwise asymptomatic individuals21; (2) a
syndrome of chronic lymphadenopathy often associated
with constitutional symptoms of non-life-threatening op¬
portunistic infections1; and (3) a state associated with
profound cell-mediated immunodeficiency with Kaposi's
fatal opportunistic infections,24"27 or a combi-
Downloaded From: http://archinte.jamanetwork.com/ by a UQ Library User  on 09/14/2015
nation of the two.5 Only the third entity is currently
classified as AIDS for the purpose of case definition.28 It is
tempting to speculate that these various categories of
disease represent manifestations of a single immunologie
insult, perhaps from the same agent, or are "stages" of an
evolving disease process. It is also possible that these
stages are unrelated to each other and may be caused by
different, unrelated events. These relationships remain
obscure, at least in part due to a paucity of detailed clinical
and immunologie data that might be useful in separating
them one from another.
In our study, patients with lymphadenopathy clearly had
histories of larger numbers of previous sexually transmit¬
ted diseases. We have found it difficult to control for the
effects of these diseases on either chronic lymphadenopathy
or immunologie variables in studies of active homosexuals
since, as shown in our study, most sexually active homosex¬
ual patients have clinical or serologie evidence of infection at
any given time. Similar numbers of patients with lympha¬
denopathy had recent active medical problems when com¬
pared with patients without lymphadenopathy; abnormali¬
ties in immunologie variables were consistent among the
two patient groups when asymptomatic subgroups of each
were studied. These results support our contention that the
two groups can be distinguished by some immunologie
tests. To the contrary, relative percentages of total  cells,
T-helper-T-inducer cells, and ratios of helper-inducer to
suppressor-cytotoxic  lymphocytes failed to distinguish
patients with lymphadenopathy from those without. These
results appear to be similar to those of a previous study,
although statistical evaluations focused on comparisons of
the two study groups to heterosexual controls.23
Homosexuals with lymphadenopathy in our study were
distinguished by several immunologie findings. Total num¬
bers of circulating lymphocytes were higher in this group
than in patients without lymphadenopathy, and greater
numbers of these lymphocytes were of the suppressor/
cytotoxic and natural killer-cell phenotypes. Functional
studies of natural killer cells have been reported in only a
few patients with AIDS,26 and in none with the chronic
lymphadenopathy syndrome. Speculation concerning the
meaning of increased numbers of natural killer cells in
homosexuals can better be made when results of such
functional studies are available. In a previous study of
immunologie abnormalities in eight homosexual men with
lymphadenopathy, total lymphocyte numbers and total
T-lymphocyte numbers were greater, but not substantially
so, in homosexuals with lymphadenopathy than without.23
To date, marked lymphopenia, which seems to predomi¬
nantly involve the OKT-4+ T-cell population over the
OKT-8 + and B-lymphocyte populations, appears to regu¬
larly develop in AIDS patients with opportunistic infec¬
tions.24'27 It has recently been suggested that a preferential
augmentation of the T-suppressor cell population as com¬
pared with a diminution of the T-helper/inducer population
may identify homosexuals with a lower risk for the develop¬
ment of Kaposi's sarcoma or opportunistic infections.29 If
this suggestion proves true, the lack of lymphopenia and the
lymphocytosis of OKT-8 + cells in homosexuals with lym¬phadenopathy in this study suggest that lymphadenopathy
in itself may not be associated with a bad prognosis.
Group 2 homosexuals were also distinguished from those
in group 1 by their degree of T-lymphocyte dysfunction, a
finding noted but not evaluated statistically in a previous
study.23 This abnormality was not explicable in our patients
by differences in the number of cultured T-helper/inducer
lymphocytes, the primary lymphocyte population respond¬
ing to PHA.30 Previous investigations have suggested that
defective lymphocyte mitogenic function in patients with
AIDS are multifactorial, and include intrinsic lymphocytedefects and absorbable T-lymphocyte-specific blocking fac¬
tors.31 Since pooled normal human serum was used in all of
our cultures, it is unlikely that blocking factors caused the
abnormalities noted. More likely is the probability that
T-suppressor/cytotoxic cells present in culture were re¬
sponsible for these more severe aberrations of lymphocytefunction. Surprisingly, percentages of "activated" mono¬
nuclear cells as detected by the presence of la surface
antigen were not greater in group 2; to the contrary, they
were greater in group 1 patients. This finding is probably
related to the fact that in cell preparations for group 1
patients there were greater percentages of monocytes that,
like lymphocytes, also may display la antigen.32 Re¬
gardless, these data show that since homosexuals with
lymphadenopathy have clinical and immunologie features
that distinguish them from those without lymphadenopa¬
thy, studies of AIDS must carefully separate the two
groups. Otherwise, the results of such studies may be
unknowingly influenced by abnormalities that predominate
in one group or the other.
The possibility that the reactive lymphadenopathy syn¬
drome represents a secondary feature of chronic viral
infection and is unrelated to AIDS has been the subject of
ongoing discussion. This is of special interest as many of the
immunologie abnormalities reported in AIDS also occur
with viral infection.33·34 The majority of our patients had
serologie evidence of infection with more than one virus, an
observation that supports this contention. In that regard,
the results of serologie studies for hepatitis  deserve
further comment. The high rate of positivity of these
studies was not in itself surprising, but the restriction of
detectable HBsAg antigenemia to patients without lymph¬
adenopathy was. Furthermore, serum samples from four of
five of these patients were evaluated on multiple occasions
and found to be persistently positive for both HBsAb and
HBsAg. This uncommon finding was recently noted in a
group of nine patients with hepatitis, six of whom had renal
disease,35 a feature not noted in our patients. The mean of
OKT-4:OKT-8 ratios and other lymphocyte variables in our
patients with both hepatitis antigen and antibody were not
different from those of the other group 1 patients, so we do
not have evidence that they were more immunosuppressed
than other patients. This possibility, however, requires
further evaluation, as does the possibility that simultane¬
ous HBsAg and HBsAb positivity is more common than
previously thought.36
The possibility that the presence of chronic active hepati¬
tis, known to be associated with lymphocyte abnormalities,
played a part in our findings can be dismissed. Only two of
our patients had mild elevations of liver enzyme levels; both
had chronic persistent hepatitis shown on biopsy spec¬
imens. In that regard, a recent study suggested that
abnormal OKT-4:OKT-8 ratios in chronic active hepatitis
may be more closely related to homosexuality than to
hepatitis.37
Acquired immune deficiency syndrome with opportunis¬
tic infections or the reactive lymphadenopathy syndrome
has been described as developing in hemophiliacs.2'4,38·39These individuals appear to have few of the risk factors for
AIDS suggested to exist in homosexual populations40 other
than chronic viral infections transmitted by blood products.
A recent report showed that hemophiliacs with lymphade¬
nopathy like homosexuals with lymphadenopathy, have
more severely depressed lymphocyte mitogenic responses
than those without lymphadenopathy.4 Higher percentages
of Leu 7 + cells in patients with lymphadenopathy than in
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those without it were also noted in that study. Further
studies are required to see if these two groups share other
clinical and immunologie abnormalities and what these
findings will tell about the cause and prognosis of the benign
reactive lymphadenopathy syndrome. We plan long-term
follow-up of all the individuals in this study, as sequential
immunologie studies will be required to determine the
importance of the immunologie differences noted between
the two homosexual groups studied.
This study was supported in part by grant 1-U01-CA34977-01 from the
National Institutes of Health, Bethesda, Md.
Lia Pedroza operated the fluorescence-activated cell sorter, Candace
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